Efficient IgG cleavage with a low immunogenicity risk enzyme, supporting clearance of neutralizing antibodies to improve gene therapy administration.
Gene Therapy
Gene therapy involves delivering genetic material to treat or prevent disease, often using viral vectors. Pre-existing neutralizing antibodies can limit the efficiency of viral vector-based gene therapies. Genovis provides unique immunoglobulin proteases that reduce these antibodies, helping improve transduction efficiency and support more consistent outcomes in gene therapy research and development.

Applications
Resources
SmartEnzymes™ for AAV Gene Therapy Applications
Download Scientific Poster

SmartEnzymes™ for Gene Therapy
Download Product Folder




